Zaire Ebolavirus Glycoprotein-directed Antibody
- Name
- Zaire Ebolavirus Glycoprotein-directed Antibody
- Accession Number
- DBCAT005871
- Description
Not Available
- Drugs
Drug Drug Description Ansuvimab A fully human monoclonal IgG1 antibody directed against the GP1,2 surface protein of Zaire ebolavirus that is an effective treatment for Ebola virus disease. - Drugs & Drug Targets
Drug Target Type Ansuvimab Envelope glycoprotein target